Skip to main content
. 2021 Jul 23;12:542342. doi: 10.3389/fphar.2021.542342

TABLE 1.

Distribution of genotype and allele frequencies along with confidence intervals among the study areas.

SNP Genotype/allele Study areas p-value a
PLC (n = 18) PVL (n = 21) NRP (n = 57) MCP (n = 44) GNP (n = 80)
CYP2D6*10 rs1065852 (100 C > T) C/C 16 (88.9%) 16 (76.2%) 40 (70.2%) 36 (81.8%) 64 (80%) 0.7681
95%CI: 65.2–98.6% 95%CI: 52.8–91.8% 95%CI: 56.6–81.6and 95%CI: 67.3–91.8% 95%CI: 69.6–88.1%
C/T 2 (11.1%) 4 (19.0%) 15 (26.3%) 7 (15.9%) 15 (18.7%)
95%CI: 1.4–34.7% 95%CI: 5.4–41.9% 95%CI: 15.5–39.7% 95%CI: 6.6–30% 95%CI: 10.9–29%
T/T 0 (0%) 1 (4.8%) 2 (3.5%) 1 (2.3%) 1 (1.3%)
95%CI: 0.0–18.5% 95%CI: 0.1–23.8% 95%CI: 0.4–12.1% 95%CI: 0.06–12% 95%CI: 0.03–6.8%
Allele C 34 (94.4%) 36 (85.7%) 95 (83.3%) 79 (89.8%) 143 (89.4%) 0.3417
95%CI: 81.3–99.3% 95%CI: 71.5–94.6% 95%CI: 75.2–89.7% 95%CI: 81.5–95.2% 95%CI: 83.5–93.7%
Allele T 34 (94.4%) 6 (14.3%) 19 (16.7%) 9 (10.2%) 17 (10.6%)
95%CI: 0.7–18.7% 95%CI: 5.4–28.5% 95%CI: 10.3–24.8% 95%CI: 4.8–18.5% 95%CI: 6.3–16.5%
HWE 1 0.338 0.6383 0.3647 1
CYP2D6*4 rs3892097 (1846 C > T) C/C 8 (44.4%) 11 (52.4%) 28 (49.1%) 19 (43.2%) 38 (47.5%) 0.5193
95%CI: 21.5–69.2% 95%CI: 29.8–74.2% 95%CI: 35.6–62.7% 95%CI: 28.3–59% 95%CI: 36.2–59%
C/T 9 (50.0%) 9 (42.9%) 21 (36.8%) 22 (50%) 28 (35%)
95%CI: 26–74% 95%CI: 21.8–65.9% 95%CI: 24.4–50.6% 95%CI: 34.6–65.4% 95%CI: 24.7–46.5%
T/T 1 (5.6%) 1 (4.8%) 8 (14%) 3 (6.8%) 14 (17.5%)
95%CI: 0.1–27.3% 95%CI: 0.1–23.8% 95%CI: 6.3–25.8 95%CI: 1.4–18.7% 95%CI: 9.9–27.6%
Allele C 25 (69%) 31 (74%) 77 (68%) 60 (68%) 104 (65%) 0.8616
95%CI: 51.9–83.6% 95%CI: 58–86.1% 95%CI: 58.1–76% 95%CI: 57.4–77.7% 95%CI: 57.1–72.4%
Allele T 11 (31%) 11 (26%) 37 (32%) 28 (32%) 56 (35%)
95%CI: 16.3–48.1% 95%CI: 13.9–42% 95%CI: 24–41.9% 95%CI: 22.3–42.6% 95%CI: 27.6–42.9%
HWE 1 1 0.233 0.488 0.048
CYP2D6*2 rs16947 (2850 G > A) G/G 16 (88.9%) 15 (71.4%) 42 (73.7%) 37 (84.1%) 65 (81.2%) 0.8048
95%CI: 65.3–98.6% 95%CI: 47.8–88.7% 95%CI: 60.3–84.5% 95%CI: 69.9–93.5% 95%CI: 71–89.1%
G/A 2 (11.1%) 5 (23.8%) 13 (22.8%) 6 (13.6%) 14 (17.5%)
95%CI: 1.4–34.7% 95%CI: 8.2–47.2% 95%CI: 12.7–35.8% 95%CI: 5.2–24.3% 95%CI: 9.9–27.6%
A/A 0 1 (4.8%) 2 (3.5%) 1 (2.3%) 1 (1.2%)
95%CI: 0–18.5% 95%CI: 0.1–23.8% 95%CI: 0.4–12.1% 95%CI: 0.06–12% 95%CI: 0.03–6.8%
Allele G 34 (94.4%) 35 (83.3%) 97 (85.1%) 80 (90.9%) 144 (90%) 0.3366
95%CI: 81.3–99.3% 95%CI: 68.6–93% 95%CI: 77.2–91.1% 95%CI: 82.9–95.6% 95%CI: 84.3–94.2%
Allele A 2 (5.6%) 7 (16.7%) 17 (14.9%) 8 (9.1%) 16 (10%)
95%CI: 0.7–18.7% 95%CI: 7–31.4% 95%CI: 8.9–22.8% 95%CI: 4–17.1% 95%CI: 5.8–15.7%
HWE 0.448 0.59 0.294 0.564 0.448
CYP2D6*41 rs28371725 (2988 G > A) G/G 16 (100%) 15 (100%) 42 (100%) 43 (97.73%) 65 (100%) n.d
95%CI: 79.4–100% 95%CI: 78.2–100% 95%CI: 91.6–100% 95%CI: 88–100% 95%CI: 94.5–100%
G/A 0 (0%) 0 (0%) 0 (%) 1 (2.27%) 0 (%)
95%CI: 0.06–12%
A/A 0 (0%) 0 (0%) 0 (%) 0 (0%) 0 (0%)
Alleles
G 32 (100%) 30 (100%) 84 (100%) 87 (98.86%) 130 (100%) n.d
95%CI: 89.1–100% 95%CI: 88.4–100% 95%CI: 95.7–100% 95%CI: 93.8–100% 95%CI: 97.2–100%
A 0 (0%) 0 (0%) 0 (%) 1 (1.14%) 0 (0%)
95%CI: 0.03–6.2%
HWE n.d n.d n.d 1 n.d

Frequencies were determined by direct counting considering the total number of subjects genotyped from each region. Confidence intervals were estimated using the Clopper-Pearson exact method.

a

p values were determined for comparisons between genotype distributions of the different areas using a Chi-square test.

PLC = Plácido de Castro; PVL = Porto Velho; NRP Novo Repartimento; MCP = Macapá; GNP = Goianésia do Pará.

HWE = Hardy-Weinberg equilibrium (p-value).